Abstract:Objective This study used magenetic resonance imaging and neuropsychological assessment techniques to compare the cognitive function before and after drug treatment for depressed patient. We aim to understand the physical variation of depressed patients′s brain. Methods The use of the drug mirtazapine,dose: 15~30 mg/d,the treatment time of 12 weeks in the control group without any intervention,as a control group of 30 normal people. through MRI testing,monitoring and comparing the morphological variation of patients′s brain before and after the treatment of antidepressant Remeron. Before and after treatment,the patients were asked to take the WMS and WCST psycholgical assessment,The extent and property of the depressed patients′ neuropsychological dysfunction were observed. Comprehensive assessment of relevance between the activation of brain and cognitive and the clinical situational change were made before and after antidepressant treatment. The assessment of efficacy was accorded to HAMD: recovery>75%,a significant improvement 74%~50%,Improvement 49%~25%,invalid<24%. The assessments were taken before and after treatment respectively. Results After treatment,the group of depressed patient showed a significant improvement in HAMD,WSM,WCST. More specifically,for WCST the number of categories,contiued mistakes,random errors were significantly less than before treatment,the correct number and the number of classificaition are also significantly higher than that before treatment,the differences were significant(P<0.01). In addition to long-term memory,all the factors in WSM were significantly different before and after Remeron treatment,including the difference between the control group and treatment group. The rate of decrease of HAMD was slightly larger than 50 percent,which indicated that an improvement of the treatment was gained. Through MRI,we found that hippocampal volume is asymmetrical on both sides in every group of the research.(left smaller than the right side of P<0.01;before the treatment the depressed patients have significantly decreased hippocampal volume on both sides when compared with after treatment group as well as the control group(P<0.01);the right amygdala is smaller than that after treatment and the control group(P<0.01);Conclusion It prove that the hippocampus and amygdala volume abnormalities of depression may constitute the basis of neurobiolgy. The limbic system plays an important role in the pathogenesis of depression.

Consensus of mirtazapine in treatment of depression

A comparative study of treatment of depression:Mirtazapine vs.fluoxepine

Randomized,multicenter,double blind comparative trial of reboxetine in the treatment of depression with or without anxiety

Efficacy and safety of olanzapine combined with fluoxetine in treatment of depression

Control study of mirtazapine and fluoxetine in therapy of depression

Expert consensus for clinical appliance of venlafaxine controlled release formulation

A Study on Mirtazapine and Citalopram in the Treatment of Depression

The Efficacy and Safety of Mirtazapine and Fluoxetine for Depression:A Meta-analysis

Serum Levels Of Brain-Derived Neurotrophic Factor And Clinical Efficacy Of Mirtazapine In Geriatric Patients With Major Depression.

Mirtazapine and Fluoxetine in the Treatment of Cardiovascular Neurosis with Depression

Effectiveness of mirtazapine as add-on to paroxetine v. paroxetine or mirtazapine monotherapy in patients with major depressive disorder with early non-response to paroxetine: a two-phase, multicentre, randomized, double-blind clinical trial

COMPARATIVE STUDY OF DRUGS IN TREATMENT OF SENILE DEPRESSION

A control study of citalopram vs. mirtazapine in senile depression

Acute Changes of Polysomnography in Major Depressive Disorder Patients Treated with Mirtazapine

Randomized Controlled Clinical Trials of Remeron and Fluoxetine in Depressive Patients

A Preliminary Study of Different Treatment Strategies for Anxious Depression.

A study of antidepressant augmentation with mirtazapine in outpatients with major depression

Influence of mirtazapine on cognitive function in patients with depression:test of a Neuropsychological Training System and a MRI study

Mirtazapine loaded polymeric micelles for rapid release tablet: A novel formulation—In vitro and in vivo studies

Comparative Study of Efficacy and Safety of Mirtozapine and Doxepine in Treatment of Patients with Post-stroke Depression

Selective Noradrenergic Activation of BDNF Translation by Mirtazapine